The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,400
Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996
Shay, D. K. (1999) · JAMA · doi:10.1001/jama.282.15.1440 · Cited by 1,385
SIGURS, N., BJARNASON, R., SIGURBERGSSON, F., & KJELLMAN, B. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9906076 · Cited by 1,131
Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., & Raz, E. (1996) · Science · doi:10.1126/science.273.5273.352 · Cited by 1,058
Induction of an interferon response by RNAi vectors in mammalian cells
Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A.-L., & Iggo, R. (2003) · Nature Genetics · doi:10.1038/ng1173 · Cited by 961
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 958
Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus
Hall, C. B., Walsh, E. E., Long, C. E., & Schnabel, K. C. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.4.693 · Cited by 774
Sigurs, N., Bjarnason, R., Sigurbergsson, F., Kjellman, B., & Björkstén, B. (1995) · Pediatrics · doi:10.1542/peds.95.4.500 · Cited by 630
Research works printed but not linked: 9
- Coffin, S.E. & Offit, P.A. New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus. Adv. Pediatr. Infect. Dis. 13, 333–348 (1997).
- Handforth, J., Friedland, J.S. & Sharland, M. Basic epidemiology and immunopathology of RSV in children. Paediatr. Respir. Rev. 1, 210–214 (2000).
- Welliver, R.C. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J. Pediatr. 143, S112–S117 (2003). · doi:10.1067/s0022-3476(03)00508-0
- Collins, P.L., Chanock, R.M. & Murphy, B.R. in Fields Virology Vol. 1, 4th edn (eds. Knipe, D.M., Howley, P.M. & Griffin, D.E.), 1443–1485 (Lippincott-Raven, Philadelphia, 2001).
- Jin, H. et al. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology 273, 210–208 (2000). · doi:10.1006/viro.2000.0393
- Hellermann, G., Mohapatra, SS. Genetic Therapy: on the brink of a newfuture. Genetic Vaccines and Ther. 1, 1–3 (2003). · doi:10.1186/1479-0556-1-1
- Leaman, D.W. et al. Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense. Virology 292, 70–77 (2002). · doi:10.1006/viro.2001.1213
- Kole, R. & Sazani, P. Antisense effects in the cell nucleus: modification of splicing. Curr. Opin. Mol. Ther. 3, 229–234 (2001).
- Atreya, P.L., Peeples, M.E. & Collins, P.L. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J. Virol. 72, 1452–1461 (1998). · doi:10.1128/jvi.72.2.1452-1461.1998
Cited by
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Chitosan-based formulations for delivery of DNA and siRNA
Mao, S., Sun, W., & Kissel, T. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.004 · Cited by 968
Filaggrin in the frontline: role in skin barrier function and disease
Sandilands, A., Sutherland, C., Irvine, A. D., & McLean, W. H. I. (2009) · Journal of Cell Science · doi:10.1242/jcs.033969 · Cited by 885
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703778104 · Cited by 658
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082242 · Cited by 504
Nanoparticles in modern medicine: state of the art and future challenges.
(2007) · PubMed Central · Cited by 484
An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection
Palliser, D., Chowdhury, D., Wang, Q.-Y., Lee, S. J., Bronson, R. T., Knipe, D. M., & Lieberman, J. (2006) · Nature · doi:10.1038/nature04263 · Cited by 410
Mehta, M., Deeksha, Tewari, D., Gupta, G., Awasthi, R., Singh, H., Pandey, P., Chellappan, D. K., Wadhwa, R., Collet, T., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.028 · Cited by 397
Marques, J. T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M. A., & Williams, B. R. (2006) · Nature Biotechnology · doi:10.1038/nbt1205 · Cited by 380
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Moschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., & Lindsay, M. A. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070077d · Cited by 350
Eguchi, A., Meade, B. R., Chang, Y.-C., Fredrickson, C. T., Willert, K., Puri, N., & Dowdy, S. F. (2009) · Nature Biotechnology · doi:10.1038/nbt.1541 · Cited by 340
Human Coronaviruses: What Do They Cause?
Van Der Hoek, L. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s01.1 · Cited by 331
RNA interference-based therapy and its delivery systems
Chen, X., Mangala, L. S., Rodriguez-Aguayo, C., Kong, X., Lopez-Berestein, G., & Sood, A. K. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9717-6 · Cited by 329
Self-citationChemical modification of chitosan as a gene carrier in vitro and in vivo
Kim, T.-H., Jiang, H.-L., Jere, D., Park, I.-K., Cho, M.-H., Nah, J.-W., Choi, Y.-J., Akaike, T., & Cho, C.-S. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.001 · Cited by 322
Liu, P., Jamaluddin, M., Li, K., Garofalo, R. P., Casola, A., & Brasier, A. R. (2007) · Journal of Virology · doi:10.1128/jvi.01740-06 · Cited by 320
Pulmonary applications and toxicity of engineered nanoparticles
Card, J. W., Zeldin, D. C., Bonner, J. C., & Nestmann, E. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2008 · Cited by 307
Wang, Q., Lee, I., Ren, J., Ajay, S. S., Lee, Y. S., & Bao, X. (2013) · Molecular Therapy · doi:10.1038/mt.2012.237 · Cited by 304
RNA interference against viruses: strike and counterstrike
Haasnoot, J., Westerhout, E. M., & Berkhout, B. (2007) · Nature Biotechnology · doi:10.1038/nbt1369 · Cited by 295
Lo, M. S., Brazas, R. M., & Holtzman, M. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9315-9319.2005 · Cited by 284
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
Nanodelivery in airway diseases: Challenges and therapeutic applications
Roy, I., & Vij, N. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.07.001 · Cited by 137
Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential
Vij, N. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.597381 · Cited by 60
Yang, K.-C., Lin, J.-C., Tsai, H.-H., Hsu, C.-Y., Shih, V., & Hu, C.-M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00965-y · Cited by 39
Genetic Modification of the Lung Directed Toward Treatment of Human Disease
Sondhi, D., Stiles, K. M., De, B. P., & Crystal, R. G. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.152 · Cited by 36
Metadata
- Authors
- Zhang, W., Yang, H., Kong, X., Mohapatra, S., Juan-Vergara, H. S., Hellermann, G., Behera, S., Singam, R., Lockey, R. F., & Mohapatra, S. S.
- Venue
- Nature Medicine
- Published
- 2004-12-26
- Volume
- 11
- Issue
- 1
- Pages
- 56-62
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101653431
- Cited by
- 365
- References
- 38
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-02-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.